[1] 沈璐,刘巍,范燕,等.论我国药品不良反应监测技术工作的发展阶段[J]. 中国药物警戒, 2012, 9(3):146-149. [2] FDA. FDA’s Sentinel Initiative[EB/OL]. (2016-11-08)[2016-11-16].http://www.fda.gov/Safety/FDAsSentinelInitiative/default.htm. [3] Sentinel Coordinating Center. SentinelMethods[EB/OL]. (2016-04-10)[2016-11-18].https://www.sentinelsystem.org/sentinel/methods. [4] 沈璐. 试论FDA”哨点行动”对我国药品不良反应监测工作的启示[J]. 中国药物警戒, 2011, 8(5):287-291. [5] 吴浩飞, 孙亨凡, 孟胜利,等. 简述疫苗安全性管理[J]. 微生物学免疫学进展, 2013,44(5):69-74. [6] Platt R, Wilson M, Chan K A, et al. The new Sentinel Network improving the evidence of medical-product safety[J]. N Engl J Med,2009,361(361):645-647. [7] Stang P E, Ryan P B, Racoonsin J A, et al. Advancing the science for active surveillance:rationale and design for the Observational Medical Outcomes Partnershop[J].Annals of internal Medicine,2010,153(9):600-606 [8] Brown J S, Holmes J H, Shah K, et al. Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care[J]. Med Care, 2010,48(Suppl):45-51. [9] 王丹.借落实《办法》良机促ADR监测工作进阶[N].《医药经济报》, 2011-06-29-1. [10] 唐凯, 刘晓强. JAVA卡技术在居民健康卡建设中的应用[J].中国卫生信息管理杂志, 2014,13(6):608-612. [11] 庞涛. 居民健康卡惠及民生[J].中国信息界: e医疗, 2013,6(10):112-112. [12] 佚名. 攻坚医改难题勇担发展重任—2012年医疗卫生信息化发展与未来展望[J].中国信息界: e医疗, 2012,5(12):40-45. |